Can we leverage immunotherapy against Alzheimer’s disease?
Currently, about 32 million people around the world live with Alzheimer's disease, the most common form of dementia.
With a growing aging population, experts expect dementia cases to spike to 152 million by 2050.Right now, there is no cure for Alzheimer’s disease, and medication options are lim
...
As jy n aktiewe intekenaar is en die artikel wys nie, meld asseblief af en weer aan. Gratis toegang tot artikels vanaf 12:00.
Kommentaar
Republikein
Geen kommentaar is op hierdie artikel gelaat nie